[EN] METHOD FOR MONITORING THE PROGRESSION OF FIBRINOLYSIS'646<br/>[FR] PROCÉDÉ DE SUIVI DE LA PROGRESSION DE LA FIBRINOLYSE
申请人:ASTRAZENECA AB
公开号:WO2009082340A1
公开(公告)日:2009-07-02
It is an object of the present invention to provide biological markers ( 'biomarkers' ) indicative for fibrinolysis. This object has been reached in that a method is provided for monitoring the progression of fibrinolysis in a subject that have received a therapeutically effective dose of a carboxypeptidase U (CPU) inhibitor, comprising detecting and quantifying the amount of protein (s) or polypeptides in a blood sample from said subject. According to another aspect of the invention, a method is provided for monitoring the progression of fibrinolysis in a subject, comprising determining the levels of fibrin fragments, in a blood sample from the subject, wherein said fibrin fragment is selected from the group consisting of the fibrin gamma-chain and fibrin α-fragments.